Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes-Reference-Cited by-同舟云学术

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

Published:2006-11-01 Issue:11 Volume:91 Page:4612-4619
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Herman Gary A.¹,Bergman Arthur¹,Stevens Catherine¹,Kotey Paul¹,Yi Bingming¹,Zhao Peng¹,Dietrich Bruno²,Golor George²,Schrodter Andreas³,Keymeulen Bart⁴,Lasseter Kenneth C.⁵,Kipnes Mark S.⁶,Snyder Karen¹,Hilliard Deborah¹,Tanen Michael¹,Cilissen Caroline⁷,De Smet Marina⁷,de Lepeleire Inge⁷,Van Dyck Kristien⁷,Wang Amy Q.¹,Zeng Wei¹,Davies Michael J.¹,Tanaka Wesley¹,Holst Jens J.⁸,Deacon Carolyn F.⁸,Gottesdiener Keith M.¹,Wagner John A.¹

Affiliation:

1. Merck Research Laboratories (G.A.H., A.B., C.S., P.K., B.Y., P.Z., K.S., D.H., M.T., A.Q.W., W.Z., M.J.D., W.T., K.M.G., J.A.W.), Rahway, New Jersey 07065

2. 3ClinicalResearch AG (B.D., G.G.), 16761 Berlin, Germany

3. Focus Clinical Drug Development GmBH (A.S.), 41460 Neuss, Germany

4. Free University of Brussels (B.K.), Brussels, 1050 Belgium

5. Clinical Pharmacology Associates (K.C.L.), Miami, Florida 33142

6. Diabetes and Glandular Disease Research Associates (M.S.K.), San Antonio, Texas 78229

7. MSD-Europe (C.C., M.D.S., I.d.L., K.V.D.), 1180 Brussels, Belgium

8. University of Copenhagen (J.J.H., C.F.D.), DK-2200 Copenhagen, Denmark

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link